Voloridge Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Buy
36,269
+35,357
+3,877% +$10.5M 0.04% 492
2025
Q4
$249K Sell
912
-17,209
-95% -$4.68M ﹤0.01% 1093
2025
Q3
$4.9M Sell
18,121
-180,111
-91% -$49M 0.02% 751
2025
Q2
$54.6M Buy
+198,232
New +$53.9M 0.2% 129
2025
Q1
Sell
-473,248
Closed -$110M 1195
2024
Q4
$110M Sell
473,248
-505,574
-52% -$116M 0.39% 48
2024
Q3
$216M Buy
978,822
+226,774
+30% +$46.9M 0.79% 8
2024
Q2
$148M Buy
752,048
+637,591
+557% +$132M 0.55% 20
2024
Q1
$24.6M Sell
114,457
-11,152
-9% -$2.34M 0.09% 278
2023
Q4
$26.5M Sell
125,609
-137,128
-52% -$29.3M 0.1% 255
2023
Q3
$52.6M Buy
262,737
+70,691
+37% +$14.1M 0.26% 98
2023
Q2
$35.6M Buy
192,046
+97,460
+103% +$18M 0.17% 171
2023
Q1
$18.1M Sell
94,586
-707,008
-88% -$128M 0.09% 315
2022
Q4
$135M Buy
801,594
+353,367
+79% +$61.4M 0.75% 9
2022
Q3
$79.4M Buy
448,227
+427,458
+2,058% +$84.5M 0.43% 35
2022
Q2
$4.25M Buy
+20,769
New +$4.4M 0.02% 737
2021
Q4
Sell
-118,136
Closed -$22.8M 1604
2021
Q3
$22.8M Buy
+118,136
New +$23.9M 0.15% 176
2021
Q1
Sell
-39,463
Closed -$7.18M 1426
2020
Q4
$7.18M Sell
39,463
-215,366
-85% -$36.6M 0.06% 365
2020
Q3
$42.6M Buy
254,829
+6,443
+3% +$1.09M 0.35% 63
2020
Q2
$40.4M Buy
248,386
+226,103
+1,015% +$40.5M 0.46% 39
2020
Q1
$3.85M Sell
22,283
-41,154
-65% -$8.19M 0.11% 201
2019
Q4
$12.7M Sell
63,437
-2,614
-4% -$536K 0.25% 94
2019
Q3
$14M Buy
66,051
+63,339
+2,336% +$13.2M 0.24% 79
2019
Q2
$526K Sell
2,712
-105,242
-97% -$19.4M 0.01% 554
2019
Q1
$17.8M Buy
+107,954
New +$19.1M 0.54% 37
2017
Q3
Sell
-86,687
Closed -$10.9M 403
2017
Q2
$10.9M Buy
+86,687
New +$10.4M 0.27% 103
2017
Q1
Sell
-209,604
Closed -$24.2M 510
2016
Q4
$24.2M Sell
209,604
-20,644
-9% -$2.3M 0.52% 39
2016
Q3
$24.1M Buy
+230,248
New +$24M 0.52% 29
2016
Q2
Sell
-58,043
Closed -$5.58M 313
2016
Q1
$5.58M Buy
+58,043
New +$5.28M 0.13% 140
2015
Q3
Sell
-92,363
Closed -$8.6M 298
2015
Q2
$8.6M Sell
92,363
-59,212
-39% -$5.52M 0.44% 60
2015
Q1
$14.4M Buy
151,575
+144,609
+2,076% +$13.4M 0.69% 40
2014
Q4
$618K Buy
+6,966
New +$590K 0.04% 172
2014
Q1
Sell
-37,819
Closed -$2.97M 86
2013
Q4
$2.97M Buy
+37,819
New +$2.96M 0.57% 55

Other funds holding CME

Voloridge Investment Management's CME Position: Q1 2026 in Review

Voloridge Investment Management increased its CME Group (CME) stake by 3,877% in Q1 2026, buying an estimated $10.5M and bringing the position to 36,269 shares worth $10.7M. The position accounts for 0.04% of the portfolio, ranked #492.

Voloridge Investment Management first reported a position in CME in Q4 2013 and has held it in 32 quarters since. The position peaked at $216M in Q3 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Voloridge Investment Management held 36,269 shares of CME Group worth $10.7M as of Q1 2026.
  • Voloridge Investment Management bought 35,357 CME Group shares in Q1 2026, an estimated $10.5M.
  • CME Group made up 0.04% of Voloridge Investment Management's portfolio in Q1 2026, its #492 holding.
  • Voloridge Investment Management first reported a position in CME Group in Q4 2013 and has held it in 32 quarters since.
  • Voloridge Investment Management's CME Group position peaked at $216M in Q3 2024.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.